4.4 Article

Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial

Related references

Note: Only part of the references are listed.
Article Statistics & Probability

mice: Multivariate Imputation by Chained Equations inR

Stef van Buuren et al.

Journal of Statistical Software (2015)

Letter Dermatology

Sitagliptin for severe psoriasis

M. Lynch et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2014)

Article Endocrinology & Metabolism

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Noriko Satoh-Asahara et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2013)

Article Dermatology

Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis

Tatsuya Nishioka et al.

DERMATOLOGY (2012)

Article Endocrinology & Metabolism

Sitagliptin Exerts an Antinflammatory Action

Antoine Makdissi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Review Endocrinology & Metabolism

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

Daniel J. Drucker et al.

DIABETES CARE (2010)

Review Medicine, General & Internal

Mechanisms of Disease: Psoriasis.

Frank O. Nestle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Dermatology

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes

R. G. van Lingen et al.

BRITISH JOURNAL OF DERMATOLOGY (2008)

Article Dermatology

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

Anja Thielitz et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)